Larimar Therapeutics Investor Presentation Deck
October 2022, 32 slides
  1. Larimar Therapeutics
  2. Related Decks
  3. Investor Presentation Decks
therapeutics | Larimar Therapeutics
forward looking statements | Larimar Therapeutics
| Larimar Therapeutics
platform technology is supported by a strong portfolio | Larimar Therapeutics
ataxia | Larimar Therapeutics
is designed to deliver additional | Larimar Therapeutics
upcoming phase four week dose exploration study | Larimar Therapeutics
phase top line data demonstrated for in | Larimar Therapeutics
phase clinical program in patients with | Larimar Therapeutics
completed multiple ascending dose study | Larimar Therapeutics
dose dependent increases in levels observed in buccal cells | Larimar Therapeutics
data compare favorably to levels expected in heterozygous carriers | Larimar Therapeutics
clinical non clinical safety data support initiation of the week phase dose exploration study cohort | Larimar Therapeutics
upcoming trials | Larimar Therapeutics
summary advancing to phase trial | Larimar Therapeutics
not | Larimar Therapeutics
therapeutics corporate clinical update | Larimar Therapeutics
therapeutics yer | Larimar Therapeutics
mad trial patient demographics | Larimar Therapeutics
mad trial patient disease characteristics | Larimar Therapeutics
dose dependent increases in levels observed in skin a | Larimar Therapeutics
dose dependent increases in levels observed in platelets with daily dosing i | Larimar Therapeutics
| Larimar Therapeutics
leadership team | Larimar Therapeutics
strong relationship with | Larimar Therapeutics
scientific advisory board | Larimar Therapeutics
positive mouse model data support development | Larimar Therapeutics
extends survival in deficient mice | Larimar Therapeutics
prevents the development of ataxic gait in mice | Larimar Therapeutics
delivers to mitochondria in mice | Larimar Therapeutics
prevents left ventricle dilation in mice | Larimar Therapeutics
preserves left ventricle function in mice | Larimar Therapeutics
See More
Larimar Therapeutics
Investor Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Vehicle
Recent decks by Larimar Therapeutics
Investor Presentation
November 2023
Results
November 2022
See all presentations by Larimar Therapeutics (3 decks)
Related decks
Taysha
IPO
September 2020
Blue Water Vaccines
Results
October 2022
Medigus
Results
October 2022
Recent decks by Larimar Therapeutics
See all presentations (3 decks)
Investor Presentation
November 2023
Results
November 2022
Taysha
IPO
September 2020
Blue Water Vaccines
Results
October 2022
Medigus
Results
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights